Literature DB >> 19161806

Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin.

Danny Del Duca1, Shashank S Sheth, Ann E Clarke, Kevin J Lachapelle, Patrick L Ergina.   

Abstract

We present two cases of catecholamine-refractory and vasopressin-refractory vasoplegic syndrome associated with intraoperative anaphylaxis during cardiac surgery. One case was related to the administration of protamine and the other case to the administration of aprotinin. Both cases were successfully managed using intravenous methylene blue. The use of methylene blue blocks accumulation of cyclic guanosine monophosphate by competitively inhibiting the enzyme guanylate cyclase. This results in reduced responsiveness of the vasculature to cyclic guanosine monophosphate-mediated vasodilators, such as nitric oxide. This report provides a description of severe anaphylaxis induced by different agents, in which the use of methylene blue was associated with a significant clinical response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19161806     DOI: 10.1016/j.athoracsur.2008.07.017

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Methylene Blue to Treat Protamine-induced Anaphylaxis Reactions. An Experimental Study in Pigs.

Authors:  Agnes Afrodite S Albuquerque; Edson A Margarido; Antonio Carlos Menardi; Adilson Scorzoni; Andrea Carla Celotto; Alfredo J Rodrigues; Walter Vilella A Vicente; Paulo Roberto B Evora
Journal:  Braz J Cardiovasc Surg       Date:  2016 May-Jun

Review 2.  Methylene blue for distributive shock: a potential new use of an old antidote.

Authors:  David H Jang; Lewis S Nelson; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2013-09

3.  A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy.

Authors:  Rachel Erin Graham; Michaela Cartner; James Winearls
Journal:  BMJ Case Rep       Date:  2015-07-06

4.  Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose.

Authors:  R L Weinberg; N C Bouchard; D C Abrams; M Bacchetta; A L Dzierba; K M Burkart; D Brodie
Journal:  Perfusion       Date:  2013-07-17       Impact factor: 1.972

5.  A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.

Authors:  Joshua Manghelli; Lisa Brown; Hany B Tadros; Nabil A Munfakh
Journal:  Tex Heart Inst J       Date:  2015-10-01

6.  Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery.

Authors:  Aly Makram Habib; Ahmed Galal Elsherbeny; Rayd Abdelaziz Almehizia
Journal:  Indian J Crit Care Med       Date:  2018-03

7.  Refractory Vasoplegic Syndrome in an Adult Patient with Infective Endocarditis: A Case Report and Literature Review.

Authors:  Seyed Mohsen Mirhosseini; Ali Sanjari Moghaddam; Paritash Tahmaseb Pour; Ali Dabbagh
Journal:  J Tehran Heart Cent       Date:  2017-01

8.  Effect of a single bolus of methylene blue prophylaxis on vasopressor and transfusion requirement in infective endocarditis patients undergoing cardiac surgery.

Authors:  Jin Sun Cho; Jong Wook Song; Sungwon Na; Joo-Hwa Moon; Young Lan Kwak
Journal:  Korean J Anesthesiol       Date:  2012-08-14

9.  IgE-Mediated Anaphylaxis to Foods, Venom, and Drugs: Influence of Serum Angiotensin Converting Enzyme Levels and Genotype.

Authors:  V A Varney; A Warner; A Ghosh; A Nicholas; N Sumar
Journal:  J Allergy (Cairo)       Date:  2012-12-19

Review 10.  Pheochromocytoma resection: Current concepts in anesthetic management.

Authors:  Harish Ramakrishna
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Jul-Sep
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.